StockClub

GANX

GANXGain Therapeutics, Inc.$ --
Gain Therapeutics, Inc.

Gain Therapeutics, Inc.

GANX

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
0M USD
YoY -
Operating Income
-5M USD
YoY -22.5%
Net Income
-6M USD
YoY -23.8%
EPS
-0.13$
YoY +18.8%

Revenue

$0
FY2024 Q2$0
$0
Q2
FY2024 Q3$0
$0
Q3
FY2024 Q4$0
$0
Q4
FY2025 Q1$0
$0
Q1
FY2025 Q2$0
$0
Q2
FY2025 Q3$0
$0
Q3
FY2025 Q4$0
$0
Q4
FY2026 Q1$0
$0
Q1
Actual
$0 (-)

Net Income

$-5.6M
FY2024 Q2$-12.2M
$-12.2M
Q2
FY2024 Q3$-16.6M
$-16.6M
Q3
FY2024 Q4$-20.4M
$-20.4M
Q4
FY2025 Q1$-4.5M
$-4.5M
Q1
FY2025 Q2$-10.3M
$-10.3M
Q2
FY2025 Q3$-15.6M
$-15.6M
Q3
FY2025 Q4$-20.2M
$-20.2M
Q4
FY2026 Q1$-5.6M
$-5.6M
Q1
Actual
$-1.1M (-23.8%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$28,881
FY2020
$28,881
FY2021MISS
Actual:$133,928
Est:$149,000
FY2021MISS
$133,928
FY2022BEAT
Actual:$132,640
Est:$125,000
FY2022BEAT
$132,640
FY2023MISS
Actual:$55,180
Est:$276,000
FY2023MISS
$55,180
FY2024MISS
Actual:$0
Est:$33,333
FY2024MISS
$0
FY2025MISS
Actual:$0
Est:$40,000
FY2025MISS
$0

Analyst Estimates